Back

Introduction and a clinical case of a patient with HFrEF

26 August 2023 (15:30 - 15:35)
Organised by: Logo
Congress Presentation Part of: Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy Chronic Heart Failure Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

4 More presentations in this session

Presentation thumbnail
The key role of RAASi-based therapy in symptomatic heart failure
Doctor S. Zieroth (Winnipeg, CA)
Slides Video
Presentation thumbnail
Clinical choices in tackling the risk of hyperkalaemia
Doctor M. Kosiborod (Kansas City, US) Doctor S. Zieroth (Winnipeg, CA) Doctor A. Wong (Bridgend, GB)
Slides Video
Presentation thumbnail
A practical model for optimising RAASi-based therapy
Doctor A. Wong (Bridgend, GB)
Slides Video
Presentation thumbnail
Summary and conclusions
Doctor M. Kosiborod (Kansas City, US)
Slides Video

Access the full session

Session thumbnail
Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 15:30 CET
You may be interested in
thumbnail
Congress Session
Tackling the risk of hyperkalaemia through guideline-recommended heart failure therapy
thumbnail
Congress Presentation
Case II: implementation of guideline-directed medical therapy
thumbnail
Congress Session
Strategies for managing hyperkalaemia in cardiorenal disease: a clinical dialogue defining a roadmap to improved outcomes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources